A drug used to slow cognitive decline in Alzheimer's disease could offer clues on how drugs might one day be able to reverse brain changes that affect learning and memory in teens and young adults who binge drink.
The study included completion of an online survey by 27 physicians, who reported working in 15 of 26 provincial correctional facilities for adults in Ontario. This included 10 of the 13 facilities with a population of more than 200. The study identified that about half of the physicians prescribed methadone and half prescribed buprenorphine/naloxone to treat opioid dependence.
A new study shows that public health and public safety agencies established local, collaborative programs in Massachusetts to connect overdose survivors and their personal networks with addiction treatment, harm reduction, and other community support services following a non-fatal overdose.
A new study in JAMA Psychiatry suggests that treating people for opioid addiction in jails and prisons is a promising strategy to address high rates of overdose and opioid use disorder.
There were fewer postincarceration deaths from overdose among recently released inmates after a program was started to provide medications for addiction treatment (including methadone, buprenorphine or naltrexone) in a state correctional system.
Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug.
Exercise has numerous, well-documented health benefits. Could it also play a role in preventing and reducing substance misuse and abuse in adolescents? In a review article recently published in Birth Defects Research, researchers supply a rationale for the use of exercise, particularly assisted exercise, in the prevention and adjunctive treatment of substance-use disorders.
The new study, published in The European Journal of Internal Medicine, found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson's disease, post-traumatic stress disorder, ulcerative colitis, Crohn's disease, multiple sclerosis, and other medical issues. After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage.
Indiana University researchers scanned the brains of individuals with alcohol abuse disorder and found that the neurotransmitter glutamate may play a role in some addiction cravings.
With states rapidly legalizing cannabis for medicinal and recreational use, physicians will be increasingly pressed to counsel patients on their frequency of use and dosage, as well as associated risks. The special report in the JAOA aggregates what is known to help physicians give the best evidence-based recommendations.